Choose License Type
The global aesthetic medicine market was valued at USD 55.8 billion in 2019 and is expected to grow at a CAGR of 9% over the forecast period. The aesthetic market will be improved by rising aesthetic understanding and a variety of non-invasive aesthetic procedures. In addition, the technical developments across the sector will increase its worldwide adoption rate. Another major factor driving growth in industry is the increasing recognition among individuals of their appearance.
The global aesthetic medicine market is categorized based on invasive procedures, and non-invasive procedures. Region wise, North America was the largest market in 2018; however, Asia Pacific is expected to be the fastest growing region by 2028, with a CAGR of 9.7%.
Key players serving the global aesthetic medicine market include Cynosure (Hologic, Inc.), Johnson & Johnson, Alma Lasers, Galderma S.A., Allergan, Inc., Solta Medical, Syneron Candela, Lumenis, Valeant International, Zeltiq Aesthetic among other prominent players.
Key segments of the global aesthetic medicine market
Invasive Procedures Overview, 2018-2028 (USD Billion)
Non-Invasive Procedures Overview, 2018-2028 (USD Billion)
Regional Overview, 2018-2028 (USD Billion)
Reasons for the study
What does the report include?
Who should buy this report?
Consultants, analysts, researchers, and academicians looking for insights shaping the global aesthetic medicine market
The number of target customers with signs of ageing, such as wrinkles, loss of skin elasticity and dark spots is expected to fuel population growth between 30 and 65 years. According to the CIA, for example, about 39.9 per cent of the German population was between 25 and 54 years old, and about 15.0 per cent of the population was between 55 and 65 years old in 2019. This aspect is expected to drive the country 's demand for aesthetic medicine in the coming years.
In addition, the need to develop aesthetics in the increasingly growing population of the working class is likely to increase the use of aesthetic medicines over this projected period. The market is anticipated to experience lucrative progress over the projection period with the improvement of jobs, especially in emerging economies. However, the adverse effects of aesthetic procedures can continue to adversely affect the consumer preference index.
The global aesthetic medicine market has been bifurcated into invasive procedures & non-invasive procedures. In the year 2019, non-invasive segment dominated the global aesthetic medicine market and is projected to witness the highest CAGR through-out the forecast period. In 2019, over 17 million minimally invasive cosmetic procedures were performed in the United States. The botox injection is considered to be the top minimally invasive cosmetic treatment according to the Plastic Surgery Statistics Study with over 7.7 million procedures carried out in the U.S. in 2019. This has resulted in strong demand for procedures that are minimally invasive and thus projected to fuel market growth further.
Based on regions, the global aesthetic medicine market is segmented into North America, Europe, Asia Pacific, South America and Middle East & Africa. In 2019, North America was the largest market globally. Some of the key factors contributing to growth are: well developed healthcare facilities, acceptance of cosmetic procedures, increased prevalence of skin disorders, and the presence of qualified and professional cosmetic surgeons across the region.
The global aesthetic medicine market was valued at USD 55.8 billion in 2019 and is expected to grow at a CAGR of 9% over the forecast period. The aesthetic market will be improved by rising aesthetic understanding and a variety of non-invasive aesthetic procedures. In addition, the technical developments across the sector will increase its worldwide adoption rate. Another major factor driving growth in industry is the increasing recognition among individuals of their appearance.
The global aesthetic medicine market is categorized based on invasive procedures, and non-invasive procedures. Region wise, North America was the largest market in 2018; however, Asia Pacific is expected to be the fastest growing region by 2028, with a CAGR of 9.7%.
Key players serving the global aesthetic medicine market include Cynosure (Hologic, Inc.), Johnson & Johnson, Alma Lasers, Galderma S.A., Allergan, Inc., Solta Medical, Syneron Candela, Lumenis, Valeant International, Zeltiq Aesthetic among other prominent players.
Key segments of the global aesthetic medicine market
Invasive Procedures Overview, 2018-2028 (USD Billion)
Non-Invasive Procedures Overview, 2018-2028 (USD Billion)
Regional Overview, 2018-2028 (USD Billion)
Reasons for the study
What does the report include?
Who should buy this report?
Consultants, analysts, researchers, and academicians looking for insights shaping the global aesthetic medicine market
Chapter 1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
Chapter 2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.3. Primary Sources
2.4. Secondary Sources
2.5. Market Size Estimation
2.6. Market Forecast
2.7. Data Triangulation
2.8. Assumptions and Limitations
Chapter 3. Market Outlook
3.1. Introduction
3.2. Macroeconomic Indicators
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Challenges
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Global Aesthetic Medicine Market by Invasive Procedures, 2018-2028 (USD Billion)
4.1.1. Breast Augmentation
4.1.2. Liposuction
4.1.3. Nose Reshaping
4.1.4. Eyelid Surgery
4.1.5. Tummy Tuck
4.1.6. Others
Chapter 5. Global Aesthetic Medicine Market by Non-Invasive Procedures, 2018-2028 (USD Billion)
5.1.1. Botox Injections
5.1.2. Soft Tissue Fillers
5.1.3. Chemical Peel
5.1.4. Laser Hair Removal
5.1.5. Microdermabrasion
5.1.6. Others
Chapter 6. Global Aesthetic Medicine Market by Region, 2018-2028 (USD Billion)
6.1. North America
6.1.1. U.S.
6.1.2. Canada
6.2. Europe
6.2.1. Germany
6.2.2. UK
6.2.3. France
6.2.4. Spain
6.2.5. Rest of Europe
6.3. Asia Pacific
6.3.1. Japan
6.3.2. China
6.3.3. India
6.3.4. Rest of Asia Pacific
6.4. South America
6.4.1. Brazil
6.4.2. Mexico
6.4.3. Rest of South America
6.5. Middle East and Africa
6.5.1. GCC
6.5.2. South Africa
6.5.3. Rest of Middle East and Africa
Chapter 7. Company Profiles
7.1. Cynosure (Hologic, Inc.)
7.1.1. Overview
7.1.2. Products and Services Portfolio
7.1.3. Recent Initiatives
7.1.4. Company Financials
7.2. Johnson & Johnson
7.2.1. Overview
7.2.2. Products and Services Portfolio
7.2.3. Recent Initiatives
7.2.4. Company Financials
7.3. Alma Lasers
7.3.1. Overview
7.3.2. Products and Services Portfolio
7.3.3. Recent Initiatives
7.3.4. Company Financials
7.4. Galderma S.A.
7.4.1. Overview
7.4.2. Products and Services Portfolio
7.4.3. Recent Initiatives
7.4.4. Company Financials
7.5. Allergan, Inc.
7.5.1. Overview
7.5.2. Products and Services Portfolio
7.5.3. Recent Initiatives
7.5.4. Company Financials
7.6. Solta Medical
7.6.1. Overview
7.6.2. Products and Services Portfolio
7.6.3. Recent Initiatives
7.6.4. Company Financials
7.7. Syneron Candela
7.7.1. Overview
7.7.2. Products and Services Portfolio
7.7.3. Recent Initiatives
7.7.4. Company Financials
7.8. Lumenis
7.8.1. Overview
7.8.2. Products and Services Portfolio
7.8.3. Recent Initiatives
7.8.4. Company Financials
7.9. Valeant International
7.9.1. Overview
7.9.2. Products and Services Portfolio
7.9.3. Recent Initiatives
7.9.4. Company Financials
7.10. Zeltiq Aesthetic
7.10.1. Overview
7.10.2. Products and Services Portfolio
7.10.3. Recent Initiatives
7.10.4. Company Financials
Chapter 8. Appendix
8.1. Primary Research Approach
8.1.1. Primary Interview Participants
8.1.2. Primary Interview Summary
8.2. Questionnaire
8.3. Related Reports
8.3.1. Published
8.3.2. Upcoming